EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs

Sara Bettonte iD, Mattia Berton iD, Manuel Battegay iD, Felix Stader iD, Catia Marzolini iD

CPT: Pharmacometrics & Systems Pharmacology · 2024

DOI: 10.1002/psp4.13118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2024. Verfasst von Sara Bettonte und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerla…. Hauptthemen laut MEDLINE: Models, Biological, Rilpivirine, Computer Simulation. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is growing interest in the use of long‐acting (LA) injectable drugs to improve treatment adherence. However, their long elimination half‐life complicates the conduct of clinical trials. Physiologically‐based pharmacokinetic (PBPK) modeling is a mathematical tool that allows to simulate unknown clinical scenarios for LA formulations. Thus, this work aimed to develop and verify a mechanistic intramuscular PBPK model. The framework describing the release of a LA drug from the depot was developed by including both the physiology of the injection site and the physicochemical properties of the drug. The framework was coded in Matlab® 2020a and implemented in our existing PBPK model for the verification step using clinical data for LA cabotegravir, rilpivirine, and paliperidone. The model was considered verified when the simulations were within twofold of observed data. Furthermore, a local sensitivity analysis was conducted to assess the impact of various factors relevant for the drug release from the depot on pharmacokinetics. The PBPK model was successfully verified since all predictions were within twofold of observed clinical data. Peak concentration, area under the concentration‐time curve, and trough concentration were sensitive to media viscosity, drug solubility, drug density, and diffusion layer thickness. Additionally, inflammation was shown to impact the drug release from the depot. The developed framework correctly described the release and the drug disposition of LA formulations upon intramuscular administration. It can be implemented in PBPK models to address pharmacological questions related to the use of LA formulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, BiologicalRilpivirineComputer SimulationHumansInjections, IntramuscularPaliperidone PalmitateDelayed-Action PreparationsMaleAdultAnti-Retroviral AgentsDrug LiberationMiddle AgedAnti-HIV AgentsFemalePyridonesDiketopiperazines

Substanzen

RilpivirinePaliperidone PalmitateDelayed-Action PreparationsAnti-Retroviral AgentsAnti-HIV AgentsPyridonesDiketopiperazinescabotegravir

Autor:innen und Institutionen

  • Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.
  • Faculty of Medicine, University of Basel, Basel, Switzerland.
  • Certara UK Limited, Sheffield, UK.
  • Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
  • Service and Laboratory of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: Sara Bettonte, Mattia Berton, Manuel Battegay, Felix Stader, Catia Marzolini

Förderung

  • Swiss National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Bettonte, S., Berton, M., Battegay, M., Stader, F., & Marzolini, C. (2024). Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13118

Vancouver

Bettonte S, Berton M, Battegay M, Stader F, Marzolini C. Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs. CPT: Pharmacometrics & Systems Pharmacology. 2024. doi:10.1002/psp4.13118

BibTeX
@article{Bettonte2024,
  author = {Bettonte, Sara and Berton, Mattia and Battegay, Manuel and Stader, Felix and Marzolini, Catia},
  title = {Development of a physiologically‐based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2024},
  doi = {10.1002/psp4.13118}
}
Kostenlos starten →